Gabriel de
Arriba de la Fuente
Catedrático/a de Universidad
Hospital del Mar
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital del Mar (9)
2022
-
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Transplantation, Vol. 106, Núm. 7, pp. 1430-1439
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19
Transplantation, Vol. 106, Núm. 5, pp. 1012-1023
-
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum
Clinical journal of the American Society of Nephrology : CJASN
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
2021
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Renin-angiotensin system blockers and the risk of covid-19–related mortality in patients with kidney failure
Clinical Journal of the American Society of Nephrology, Vol. 16, Núm. 7, pp. 1061-1072
2020
-
COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983